NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 81 filers reported holding NEVRO CORP in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $17,511,000 | -30.0% | 216,000 | -44.0% | 0.37% | -59.2% |
| Q2 2019 | $25,024,000 | -30.9% | 386,000 | -33.4% | 0.90% | -35.3% |
| Q1 2019 | $36,222,000 | +1.9% | 579,463 | -36.6% | 1.39% | -2.4% |
| Q4 2018 | $35,556,000 | +18.8% | 914,273 | +74.1% | 1.42% | +32.7% |
| Q3 2018 | $29,927,000 | +6.8% | 525,040 | +39.5% | 1.07% | -28.2% |
| Q2 2017 | $28,009,000 | -25.8% | 376,308 | -6.6% | 1.49% | +2.6% |
| Q1 2017 | $37,761,000 | -30.8% | 402,998 | -46.4% | 1.46% | -35.2% |
| Q4 2016 | $54,589,000 | -2.5% | 751,298 | +40.1% | 2.25% | -13.7% |
| Q3 2016 | $55,990,000 | +38.3% | 536,355 | -48.8% | 2.60% | +79.0% |
| Q4 2014 | $40,491,000 | – | 1,047,093 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |